Screening for depression with Centre for Epidemiological Studies Depression Scale Revised and its implication for consultation-liaison psychiatry practice among cancer subjects: a perspective from a developing country

Objective Co‐morbidity of depressive symptomatology is a common indication for use of mental health services in oncology. In this regard, screening instruments are useful for prompt identification of mental disorders in cancer. This study is set to evaluate the diagnostic validity of Centre for Epid...

Full description

Saved in:
Bibliographic Details
Published in:Psycho-oncology (Chichester, England) England), 2013-08, Vol.22 (8), p.1901-1906
Main Authors: Olagunju, Andrew T., Aina, Olatunji F., Fadipe, Babatunde
Format: Article
Language:English
Subjects:
Adult
Aged
Cancer
CES-DR
Clinical assessment
consultation-liaison
Depression
Depression - diagnosis
Depression - epidemiology
Depressive Disorder - diagnosis
Depressive Disorder - epidemiology
Epidemiologic Studies
Epidemiology
Female
Humans
Liaison psychiatry
Male
Mass Screening - methods
Medical screening
Mental depression
Mental health care
Middle Aged
Neoplasms - psychology
oncology
Predictive Value of Tests
Primary Health Care
Psychiatric disorders
Psychiatric Status Rating Scales
Psychiatry
Referral and Consultation
Reproducibility of Results
Screening
Sensitivity and Specificity
Socioeconomic Factors
Surveys and Questionnaires
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective Co‐morbidity of depressive symptomatology is a common indication for use of mental health services in oncology. In this regard, screening instruments are useful for prompt identification of mental disorders in cancer. This study is set to evaluate the diagnostic validity of Centre for Epidemiological Studies Depression Scale Revised (CES‐DR) for depression screening in cancer. Methods The CES‐DR and the Schedule for Clinical Assessment in Neuropsychiatry (SCAN) were administered by the researchers on 200 attendees of a Nigerian hospital with histological diagnoses of cancer. Subsequently, the diagnostic validity of CES‐DR was compared with SCAN. Results Ninety‐eight (49.0%) participants had significant depressive symptomatology (CES‐DR scores of ≥16) as against the diagnosis of depression in 55 (27.5%) participants following SCAN interview. Furthermore, of these 55 (27.5%) depressed participants, two (3.6%) participants had CES‐DR scores
ISSN:1057-9249
1099-1611
DOI:10.1002/pon.3234